Read + Share
Paulsen FO, Seidel C. Editorial Comment to Phase II trial of nivolumab monotherapy and biomarker
screening in patients with chemo-refractory germ cell tumors. Int J Urol 2022 May 31. doi: 10.1111/iju.14949.
PMID: 35640915
|
 |
|
Paulsen FO, Seidel C. Editorial Comment to Phase II trial of nivolumab monotherapy and biomarker
screening in patients with chemo-refractory germ cell tumors. Int J Urol 2022 May 31. doi: 10.1111/iju.14949.
PMID: 35640915
|
|
|
|